| ORIGINAL ARTICLE |
|
| Year : 2021 | Volume
: 5
| Issue : 2 | Page : 49-54 |
|
|
Conservative management of rhabdomyosarcoma of uterine cervix: A case series
Susan Mathews, PS Veena, Nithiyaanandan Natarajan
Department of Radiation Oncology, Regional Cancer Centre, Thiruvananthapuram, Kerala, India
Correspondence Address:
Susan Mathews
Department of Radiation Oncology, Regional Cancer Centre, Thiruvananthapuram, Kerala
India
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/oji.oji_5_21
|
|
|
Background: Rhabdomyosarcoma (RMS) of the uterine cervix is a rare disease, usually affects pediatric and adolescent girls. Excellent treatment outcomes have been reported with combined modality treatment employing surgery, chemotherapy, and radiation therapy. Fertility-sparing treatment options can be considered in young patients without compromising outcome. Aim: This study aimed to analyze the outcome of patients with cervical RMS who were managed conservatively. Materials and Methods: We retrospectively reviewed the clinical and pathologic data of all patients with cervical RMS who were registered at our institution during 1995–2010. Long-term outcome data of patients who had conservative surgery were analyzed. Results: During this period, six patients with cervical RMS were registered. Five patients, managed conservatively, were eligible for analysis. The median age was 20 years (range: 14–21 years). Excessive vaginal discharge was the most common presenting symptom (n = 3). All patients initially had either a polypectomy (n = 4) or gross tumor resection (n = 1) followed by received chemotherapy with VAC regimen (Vincristine, Actinomycin-D and Cyclophosphamide). One patient received local radiation (HDR brachytherapy) for microscopic residual disease. All patients were disease-free at the completion of primary therapy. At a median follow-up of 10 years, four patients remain relapse-free; three, having retained fertility, had successful pregnancies and healthy children. One patient developed ovarian failure consequent to radiation treatment but remains disease free. One patient developed local recurrence, 8 years after primary treatment, and underwent salvage hysterectomy followed by second-line chemotherapy. This patient too remains disease-free, 3 years after salvage treatment. Conclusion: RMS of the uterine cervix is highly curable in early stages. The focus now is on improving the quality of life by reducing treatment-related morbidity and late effects. Fertility preservation approaches should be considered in young females with RMS of cervix.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
